The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRLD.L Regulatory News (RLD)

  • There is currently no data for RLD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Schedule One - Richland Resources Ltd

10 Nov 2020 08:00

RNS Number : 7337E
AIM
10 November 2020
 

 

ANNOUNCEMENT TO BE MADE BY THE AIM APPLICANT PRIOR TO ADMISSION IN ACCORDANCE WITH RULE 2 OF THE AIM RULES FOR COMPANIES ("AIM RULES")

COMPANY NAME:

Richland Resources Ltd ("Richland" or the "Company")

 

COMPANY REGISTERED OFFICE ADDRESS AND IF DIFFERENT, COMPANY TRADING ADDRESS (INCLUDING POSTCODES) :

Clarendon House, 2 Church Street, Hamilton, HM 11, Bermuda

 

COUNTRY OF INCORPORATION:

Bermuda

 

COMPANY WEBSITE ADDRESS CONTAINING ALL INFORMATION REQUIRED BY AIM RULE 26:

www.richlandresourcesltd.com

 

COMPANY BUSINESS (INCLUDING MAIN COUNTRY OF OPERATION) OR, IN THE CASE OF AN INVESTING COMPANY, DETAILS OF ITS INVESTING POLICY). IF THE ADMISSION IS SOUGHT AS A RESULT OF A REVERSE TAKE-OVER UNDER RULE 14, THIS SHOULD BE STATED:

 

Admission is sought as a result of a reverse takeover in accordance with AIM Rule 14.

 

On 31 December 2019, further to the receipt of shareholder approval at an annual general meeting of the Company held on 19 August 2019, Richland became an AIM Rule 15 cash shell upon completion of a fundamental disposal and thereafter commenced the process of appraising suitable reverse acquisition opportunities in the mining sector.

 

On 24 July 2020, the Company entered into a conditional acquisition agreement to acquire the entire issued share capital of Global Asset Resources Ltd ("GAR"), for:

 

Initial consideration of AU$60,000 (approximately US$43,392) in cash and AU$1.04m (approximately US$752,128) in new common shares to be issued at a price of 2.75p per share. In addition, Richland made two non-refundable cash payments to GAR of US$29,340 on 31 July 2020 and US$22,818 on 30 September 2020.

 

Deferred consideration comprising potential future additional payments to be made to the sellers and the joint venture partner, Uwharrie Resources Inc. ("URI"), in cash or new common shares at Richland's sole discretion, of, in aggregate, AU$1.5m and AU$3m, subject to the achievement of certain material, value-generative performance milestones, or the occurrence of certain vesting events within five years of Admission.

 

GAR, via its wholly owned US subsidiary, holds a 51% interest in four gold exploration projects in North and South Carolina, being:

the Jones-Keystone-Loflin Project

the Carolina Belle Project

the Jennings-Pioneer Project; and

the Argo Project

(together, the "GAR Projects").

 

The Company has conditionally raised, in aggregate, £3.33 million via the issue of 120,989,112 new common shares of US$0.003 each (post a proposed 1 for 10 share consolidation) at a price of 2.75p per share (the "Placing and Subscription"). The net proceeds of the Placing and Subscription will be utilised to satisfy the initial consideration and to provide the Company with working capital to conduct its initial exploration programme (including meeting certain minimum funding requirements in respect of the GAR Projects during the first two years following Admission).

 

The acquisition constitutes a reverse takeover pursuant to AIM Rule 14 and is therefore subject to, inter alia, the approval of Richland's shareholders.

 

DETAILS OF SECURITIES TO BE ADMITTED INCLUDING ANY RESTRICTIONS AS TO TRANSFER OF THE SECURITIES (i.e. where known, number and type of shares, nominal value and issue price to which it seeks admission and the number and type to be held as treasury shares):

Common shares of US$0.003 each in the Company ("Common Shares") (following a proposed 1 for 10 share consolidation of the Company's existing common shares of US$0.0003 each).

 

261,478,810 Common Shares are to be admitted to trading.

 

1,108,172,891 existing common shares of US$0.0003 are currently in issue (excluding treasury shares) and will, subject to shareholder approval, be consolidated into 110,817,289 Common Shares. In addition, the Company will, on Admission, issue 120,989,112 Common Shares pursuant to the Placing and Subscription, 21,367,288 Common Shares to satisfy the initial equity consideration, 2,840,909 Common Shares to satisfy the settlement of an outstanding loan and 5,464,212 Common Shares pursuant to the satisfaction of certain outstanding fees.

 

CAPITAL TO BE RAISED ON ADMISSION (AND/OR SECONDARY OFFERING) AND ANTICIPATED MARKET CAPITALISATION ON ADMISSION:

Capital raised on Admission of £3,327,201

Implied market capitalisation on Admission of £7,190,667 at the placing price

 

PERCENTAGE OF AIM SECURITIES NOT IN PUBLIC HANDS AT ADMISSION:

52.74

 

DETAILS OF ANY OTHER EXCHANGE OR TRADING PLATFORM TO WHICH THE AIM SECURITIES (OR OTHER SECURITIES OF THE COMPANY) ARE OR WILL BE ADMITTED OR TRADED:

N/A

 

FULL NAMES AND FUNCTIONS OF DIRECTORS AND PROPOSED DIRECTORS (underlining the first name by which each is known or including any other name by which each is known):

 

Directors

Edward (Ed) Francis Gerrard Nealon (Non-Executive Chairman)

Bernard Olivier (Chief Executive Officer)

Melissa Josephine Sturgess (Non-Executive Director)

 

Proposed Director

Rhoderick (Rhod) Gordon John Grivas (Non-Executive Director)

 

FULL NAMES AND HOLDINGS OF SIGNIFICANT SHAREHOLDERS EXPRESSED AS A PERCENTAGE OF THE ISSUED SHARE CAPITAL, BEFORE AND AFTER ADMISSION (underlining the first name by which each is known or including any other name by which each is known):

 

Shareholder

Pre Admission (%)

Post Admission (%)

Orasa (a.k.a Doris) Chiaratanasen

-

13.9

Pure Ice Ltd.

-

13.9

Mark Mitchell Greenwood

29.9

12.7

Argon Financial Limited

-

4.2

Nicholas Sibley

5.9

Below 3%

Anthony Brooke

5.0

Below 3%

Strategic Investments International Ltd

4.9

Below 3%

Louis Swart

4.6

Below 3%

Ashwath Mehra

3.3

Below 3%

 

 

NAMES OF ALL PERSONS TO BE DISCLOSED IN ACCORDANCE WITH SCHEDULE 2, PARAGRAPH (H) OF THE AIM RULES:

N/A

 

(i) ANTICIPATED ACCOUNTING REFERENCE DATE

(ii) DATE TO WHICH THE MAIN FINANCIAL INFORMATION IN THE ADMISSION DOCUMENT HAS BEEN PREPARED (this may be represented by unaudited interim financial information)

(iii) DATES BY WHICH IT MUST PUBLISH ITS FIRST THREE REPORTS PURSUANT TO AIM RULES 18 AND 19:

 

(i) 31 December

 

(ii)

Unaudited half-yearly accounts for Richland to 30 June 2020 incorporated by reference

Unaudited half-yearly accounts for GAR to 31 December 2019 included within the Admission Document

 

(iii) 30 June 2021, 30 September 2021, 30 June 2022

 

EXPECTED ADMISSION DATE:

25 November 2020

 

NAME AND ADDRESS OF NOMINATED ADVISER:

 

Strand Hanson Limited

26 Mount Row, London W1K 3SQ

 

NAME AND ADDRESS OF BROKER:

 

Peterhouse Capital Limited

3rd Floor, 80 Cheapside, London EC2V 6EE

 

OTHER THAN IN THE CASE OF A QUOTED APPLICANT, DETAILS OF WHERE (POSTAL OR INTERNET ADDRESS) THE ADMISSION DOCUMENT WILL BE AVAILABLE FROM, WITH A STATEMENT THAT THIS WILL CONTAIN FULL DETAILS ABOUT THE APPLICANT AND THE ADMISSION OF ITS SECURITIES:

 

www.richlandresourcesltd.com

 

Copies of the Admission Document, which contains full details of Richland and its securities, are also available at the offices of Joelson JD LLP at 30 Portland Place, Marylebone, London W1B 1LZ

 

THE CORPORATE GOVERNANCE CODE THE APPLICANT HAS DECIDED TO APPLY

 

QCA Corporate Governance Code

 

DATE OF NOTIFICATION:

 

10 November 2020

 

NEW/ UPDATE:

 

NEW

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PAABLBRTMTMMBJM
Date   Source Headline
7th Dec 20203:00 pmRNSChange of Name and Grant of Options
3rd Dec 20201:54 pmRNSHolding(s) in Company
23rd Nov 20204:45 pmRNSResult of AGM and Total Voting Rights
10th Nov 20208:00 amRNSSchedule One - Richland Resources Ltd
2nd Nov 20207:00 amRNSUpdate re Proposed Reverse Takeover Transaction
29th Sep 20203:30 pmRNSInterim Results for half-year ended 30 June 2020
27th Jul 20207:00 amRNSProposed Reverse Takeover Transaction
1st Jul 20207:30 amRNSSuspension of Trading on AIM & Corporate Update
1st Jul 20207:30 amRNSSuspension - Richland Resources Ltd
23rd Apr 20202:05 pmRNSSecond Price Monitoring Extn
23rd Apr 20202:01 pmRNSPrice Monitoring Extension
23rd Apr 202010:15 amRNSHolding(s) in Company
7th Apr 202011:15 amRNSFinal Results
2nd Apr 20204:41 pmRNSSecond Price Monitoring Extn
2nd Apr 20204:36 pmRNSPrice Monitoring Extension
31st Mar 202010:00 amRNSHolding(s) in Company
20th Mar 20202:20 pmRNSHolding(s) in Company
17th Mar 20204:41 pmRNSSecond Price Monitoring Extn
17th Mar 20204:36 pmRNSPrice Monitoring Extension
12th Mar 20203:30 pmRNSPlacing of approximately £100,000 gross
10th Mar 20204:12 pmRNSHolding(s) in Company
3rd Mar 202011:02 amRNSHolding(s) in Company
26th Feb 20202:47 pmRNSHolding(s) in Company
13th Jan 20207:00 amRNSEquity Fundraising of £150,000
2nd Jan 20207:00 amRNSCompletion of Disposal of Capricorn Sapphire
23rd Dec 20197:00 amRNSExtension and Amendment to Option Agreement
16th Dec 20197:00 amRNSExtension and Amendment to Option Agreement
9th Dec 20197:00 amRNSFurther Extension to Amended Option Agreement
18th Nov 20197:00 amRNSExtension to Amended Option Agreement
31st Oct 20199:04 amRNSExtension to Amended Option Agreement
30th Sep 20197:00 amRNSInterim Results for half-year ended 30 June 2019
29th Aug 20192:30 pmRNSFee Conversions and Director's Dealing
21st Aug 20199:01 amRNSHolding(s) in Company
19th Aug 20194:53 pmRNSHolding(s) in Company
19th Aug 20194:51 pmRNSHolding(s) in Company
19th Aug 20193:47 pmRNSResult of AGM and Update re: Option Agreement
29th Jul 20198:39 amRNSNotice of Annual General Meeting
22nd Jul 20197:00 amRNSAmendment to Option Agreement
18th Jul 201910:47 amRNSUpdate re: Option Agreement
9th Jul 20191:03 pmRNSHolding(s) in Company
9th Jul 201912:32 pmRNSHolding(s) in Company
9th Jul 201912:27 pmRNSHolding(s) in Company
4th Jul 20197:15 amRNSEquity Fundraising & Appointment of Broker
28th Jun 201911:30 amRNSFinal Results
3rd Jun 20197:00 amRNSExtension of Loan Facility and Strategy Update
1st May 20197:30 amRNSExtension of Loan Facility and Strategy Update
1st Apr 20197:00 amRNSExtension of Loan Facility and Strategy Update
28th Feb 201912:00 pmRNSExtension of Loan Facility and Strategy Update
2nd Jan 20197:00 amRNSStrategic update and Convertible Loan Facility
28th Sep 20184:20 pmRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.